Skip to content
Mount Judi Ventures
4baseCare
← Portfolio
Healthcare·Series A·2022·Active

4baseCare

Precision oncology, accessible to every patient.

4baseCare logo
Sector
Healthcare
Stage
Series A
Year of investment
2022
Status
Active
Founders
Hitesh Goswami · Kshitij Rishi

Overview

4baseCare is making cancer genomic testing accessible across emerging markets through a proprietary AI-driven reporting platform used by oncologists worldwide.

Why MJV invested

Precision oncology in India needs founders who can hold clinical rigour and software velocity in the same head. Hitesh and Kshitij do — and their refusal to treat the South Asian genome as an afterthought is why we believe 4baseCare can define this category for emerging markets. What convinced us most was how deeply the team had thought about the oncologist's workflow, not just the science: the reports, the turnaround times, the tumour boards, the tough conversations with families. That empathy — combined with genuine research depth — is a rare compounding moat, and one we wanted to back for the long arc.

  • 01

    Proprietary South Asian cancer variant database

  • 02

    Software-led economics layered on regulated diagnostics

  • 03

    Clinical co-founders with global oncology relationships

Founders

Press & Media

  1. Economic Times — 4baseCare raises Rs 128 crore to take its cancer testing platform global
  2. YourStory — Oncology startup 4baseCare closes Rs 128 Cr Series B round
  3. ET Entrepreneur — 4baseCare secures ₹128 Crore in Series B funding

Founder on MJV

"MJV didn't just write a cheque — they sat with us through the hardest hiring and partnership decisions."
— Hitesh Goswami, Co-founder

Building in the same category?

Pitch us →